News | Cardiac PACS | March 07, 2017

Adventist Health System Selects Lumedx Data Intelligence Solutions to Enhance Cardiovascular Care

The multiphase project will begin implementation at Florida Hospital Tampa

Lumedx, Adventist Health System, CVIS, Florida

March 7, 2017 — Lumedx Corp. announced recently it has been chosen by Adventist Health System to provide a cardiovascular information system (CVIS) designed to help the faith-based healthcare system further enhance cardiovascular care delivery. Solutions to be deployed include software for analytics, reporting workflows, cardiology picture archiving and communication system (PACS) integration, inventory management and scheduling.

Adventist Health System is a faith-based healthcare organization headquartered in Altamonte Springs, Fla., with 45 hospital campuses and more than 8,300 licensed beds in nine states. Phase 1 of the long-term, multiphase CVIS project will be implemented at Florida Hospital Tampa, where clinicians have performed more than 76,000 angioplasty procedures and more than 11,000 open-heart surgeries. The second phase of the project will be implemented at nine Central Florida facilities.

Prior to selecting Lumedx, Adventist Health System conducted a detailed analysis that consisted of a comprehensive evaluation of its systems, process and protocols.

“Working with Lumedx enables us to implement a single system to manage our cardiology services across our system,” said Jackie Willis, vice president and chief clinical information officer for Adventist Health System’s information technology department. “This solution will allow us to collect data across our healthcare system to enhance clinical workflow and identify best-practice approaches, which will ultimately increase efficiency and streamline processes for care delivery for our patients.”  

The Lumedx solution will:

  • Provide analytical tools that facilitate data-driven decisions in Adventist Health System’s cardiovascular service lines;
  • Connect independent data sources;
  • Eliminate duplicative data collection;
  • Provide remote access to the CVIS for physicians;
  • Provide a comprehensive structured reporting solution with systemwide image management; and
  • Support compliance with federal, state and professional oversight bodies.

Watch the VIDEO “Lumedx Cardiovascular Performance Program: A New Approach to Managing Quality and Cost.”

For more information: www.lumedx.com

Related Content

A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Dabigatran Reduces Major Cardiovascular Complications in Patients With Myocardial Injury after Noncardiac Surgery
News | ACC | March 20, 2018
March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart att
Statins May Bring Benefits at Time of Treatment for Heart Attack, Angina

Image from presentation, "Statins Evaluation in Coronary Procedures and Revascularization," Berwanger 

News | ACC | March 20, 2018
March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broa
Overlay Init